BioCatalystWatch
CLRBWorkspace / CLRB / OverviewCompany library
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc. (CLRB)

Website

Price
Market cap
Next catalystDec 12, 2026Iopofosine I 131 — IRIS WaM confirmatory trial · Conference presentationCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

CLR 225

Radiopharmaceutical

Lipid rafts

Upcoming / outlook

CLR 125

Radiopharmaceutical

PreINDP1P2P3FilingApproved
Upcoming / outlook

Radiopharmaceutical

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Radiopharmaceutical

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

CLR 225

Radiopharmaceutical

Lipid rafts

Upcoming / outlook

CLR 125

Radiopharmaceutical

PreINDP1P2P3FilingApproved
Upcoming / outlook

Radiopharmaceutical

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Radiopharmaceutical

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

CLR 125

Radiopharmaceutical

CLR 125

Radiopharmaceutical

CLR 125

Radiopharmaceutical

Iopofosine I-131

Radiopharmaceutical

PreINDP1P2P3FilingApproved
Iopofosine I-131

Radiopharmaceutical

PreINDP1P2P3FilingApproved
Iopofosine I-131

Radiopharmaceutical

PreINDP1P2P3FilingApproved
Iopofosine I-131

Radiopharmaceutical

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

CLRB PR & News

PR & News

CLRB SEC archive